President Trump announced that human trials for a coronavirus vaccine began in record time, just eight weeks after the genetic sequence was published. The hosts discuss "Gene 133" and CRISPR technology, suggesting the new treatment is not a traditional vaccine but a genetic insertion designed to create protective plasma. They question the lack of detailed media reporting on the mechanics of these new medical technologies.
